Open Source Tool Predicts Chemo Drugs Best Suited for Individual Patients

November 12, 2018 12:09 am

Researchers at Georgia Institute of Technology (Georgia Tech) have developed a new open-source decision support tool designed to help clinicians chose the chemotherapy drug best suited for individual patients.

The open-source support vector machine (SVM)-based algorithm predicted the chemotherapy drug … Read more

2 Ovarian Cancer Survivors, 1 Shared Passion

November 13, 2017 7:27 pm

Anne Hermiller and Sarah Ludinich experienced ovarian cancer at different stages in life. What’s similar is their passion for making other women more aware of the disease and its effects.

Hermiller, of Findlay, learned she had cancer in 2014. “I … Read more

New Data Confirms Standard Dosing of Chemotherapy

September 15, 2017 3:00 pm

Women with ovarian cancer can safely stick to the standard 3-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to results of the phase III ICON8 trial to be presented at the ESMO 2017 … Read more

New Study: Improve Chemotherapy Strategies for Ovarian Cancer

May 24, 2017 6:46 pm

Most women diagnosed with ovarian cancer undergo surgery to remove as many of the tumors as possible. However, it is usually impossible to eliminate all of the cancer cells because they have spread throughout the abdomen. Surgery is therefore followed … Read more

Patients Rank Nausea as Most Concerning Chemotherapy Side Effect

March 16, 2017 6:26 pm

Patients with newly diagnosed ovarian cancer rank nausea as the most concerning side effect associated with chemotherapy, according to a study presented at the 2017 Society of Gynecologic Oncology Annual Meeting.1

An important aspect of shared decision-making is patient preference … Read more

What’s the Best Chemotherapy Strategy in Ovarian Cancer?

January 30, 2017 9:41 pm

Results from the Gynecologic Oncology Group (GOG) 252 trial, while highly anticipated in the oncology community, did not give any additional clarity for the use of intravenous (IV) versus intraperitoneal (IP) chemotherapy for patients with ovarian cancer, says Franco M. … Read more

More Chemo May Not Equal Better Outcomes in Ovarian Cancer

January 23, 2017 7:56 pm

Increasing the number of cycles of chemotherapy doesn’t appear to significantly influence recurrence rates or survival in patients with early stage ovarian clear cell carcinoma (OCCC), according to researchers.

The retrospective cohort study of 201 patients showed that recurrence and … Read more

Combination Of Chemotherapy And Immunotherapy May Be Effective

June 8, 2016 7:04 pm

Inside each ovarian tumor, there are good cells and bad cells. A new paper explains their roles: The bad cells are fibroblasts. They work to block chemotherapy, which is why nearly every woman with ovarian cancer becomes resistant to treatment. … Read more